Teuber G - Search Results

1

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

Halangk J, Sarrazin C, Neumann K, Puhl G, Mueller T, Teuber G, Klinker H, Hinrichsen H, Buggisch P, Landt O, Weich V, Bergk A, Wiedenmann B, Neuhaus P, Berg T, Witt H. Halangk J, et al. Among authors: teuber g. J Hepatol. 2008 Sep;49(3):339-45. doi: 10.1016/j.jhep.2008.05.021. Epub 2008 Jun 23. J Hepatol. 2008. PMID: 18644651

2

Interferon-alpha retreatment in chronic hepatitis C.

Gerken G, Teuber G, Goergen B, Meyer zum Büschenfelde KH. Gerken G, et al. Among authors: teuber g. J Hepatol. 1995;22(1 Suppl):118-21. J Hepatol. 1995. PMID: 7602063 Clinical Trial.

3

Risk factors for the transmission of hepatitis C.

Zeuzem S, Teuber G, Lee JH, Rüster B, Roth WK. Zeuzem S, et al. Among authors: teuber g. J Hepatol. 1996;24(2 Suppl):3-10. J Hepatol. 1996. PMID: 8836883

4

Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C.

Dietrich CF, Lee JH, Herrmann G, Teuber G, Roth WK, Caspary WF, Zeuzem S. Dietrich CF, et al. Among authors: teuber g. Hepatology. 1997 Aug;26(2):467-72. doi: 10.1002/hep.510260230. Hepatology. 1997. PMID: 9252160

5

Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus.

Lee JH, von Wagner M, Roth WK, Teuber G, Sarrazin C, Zeuzem S. Lee JH, et al. Among authors: teuber g. J Hepatol. 1998 Jul;29(1):29-35. doi: 10.1016/s0168-8278(98)80175-x. J Hepatol. 1998. PMID: 9696489

6

Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.

Sarrazin C, Berg T, Lee JH, Teuber G, Dietrich CF, Roth WK, Zeuzem S. Sarrazin C, et al. Among authors: teuber g. J Hepatol. 1999 Jun;30(6):1004-13. doi: 10.1016/s0168-8278(99)80253-0. J Hepatol. 1999. PMID: 10406177

7

Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.

Hoffmann RM, Berg T, Teuber G, Prümmer O, Leifeld L, Jung MC, Spengler U, Zeuzem S, Hopf U, Pape GR. Hoffmann RM, et al. Among authors: teuber g. Z Gastroenterol. 1999 Aug;37(8):715-23. Z Gastroenterol. 1999. PMID: 10494606 Clinical Trial.

8

Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C.

Teuber G, Berg T, Hoffmann RM, Leifeld L, Lafrenz M, Spengler U, Pape GR, Hopf U, Zeuzem S. Teuber G, et al. Digestion. 2000;61(2):90-7. doi: 10.1159/000007740. Digestion. 2000. PMID: 10705172 Free article. Clinical Trial.

9

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.

Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S. Sarrazin C, et al. Among authors: teuber g. Hepatology. 2000 Oct;32(4 Pt 1):818-23. doi: 10.1053/jhep.2000.17709. Hepatology. 2000. PMID: 11003628

10

Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.

Zeuzem S, Teuber G, Naumann U, Berg T, Raedle J, Hartmann S, Hopf U. Zeuzem S, et al. Among authors: teuber g. Hepatology. 2000 Oct;32(4 Pt 1):835-41. doi: 10.1053/jhep.2000.17740. Hepatology. 2000. PMID: 11003631 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters